HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- ‘Disconnect’ blamed for potential overuse of inferior vena cava filters
-
- Significance of persistent Epstein-Barr virus DNA remains unclear Barbara A. Burtness, MD
- Carfilzomib-based combination improves multiple myeloma survival
- Chi Van Dang, MD, PhD, appointed professor at The Wistar Institute
- Combination of binimetinib, encorafenib extends PFS in advanced BRAF–mutated melanoma
- Fox Chase Cancer Center appoints urologic oncology division chief
- Mobile lung cancer screening unit may reduce disparities, late-stage diagnoses
- Nivolumab extends survival in resected, high-risk melanoma
- Palliative Care Leadership Centers expand into community setting
-
- Seattle Genetics, Genentech to collaborate on trial for metastatic triple-negative breast cancer
- Task force maintains recommendation against ovarian cancer screening
- Vulgarity is not Washington’s only problem Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- FDA advisory committee supports three oncology products
- FDA approves optical imaging agent to assist in resection of high-grade glioma
- FDA grants orphan drug designation to several agents for solid tumors
- FDA grants priority review to Vyxeos for AML
- FDA rejects Pfizer's Epogen biosimilar for anemia
-
- Skeletal metastases in breast carcinoma: classic patterns of treatment response Munir Ghesani, MD, FACNM; Ana M. Franceschi, MD
- CDC: Cancer death rate higher in rural America
- Early palliative care benefits children with cancer
- High-grade dysplasia increases long-term risk for HPV-related cancers
- HIV may prompt progression of HPV infection to cervical precancer
- Lenvatinib improves OS in older patients with differentiated thyroid cancer
- Localized prostate cancer treatment options lead to different sexual functioning, quality-of-life outcomes
- Many ‘narrow network’ insurance plans exclude top cancer centers
-
- Medicaid rollback could increase late-stage breast cancer diagnoses
- Nivolumab benefits patients with melanoma treated beyond progression
- Overreporting of medication use common for children with ALL
- Race, ethnicity impact use of autologous stem cell transplantation for multiple myeloma
- Statins show no survival benefit in small-cell lung cancer
- Testosterone treatment increases hemoglobin levels, improves anemia in older men
- Women who survived cancer experience chemotherapy-induced neuropathy years after treatment
- Adjuvant chemotherapy shows no benefit in advanced nasopharyngeal carcinoma
-
- Adjuvant pertuzumab offers modest benefit for HER-2-positive breast cancer
- Alectinib better prevents NSCLC growth compared with crizotinib
- Immunotherapy may slow growth of relapsed mesothelioma
- Epacadostat, nivolumab combination shows promise in certain advanced solid tumors
- High-intensity genomic assay shows promise for early detection of cancer
- High-risk women with endometrial cancer often do not receive genetic counseling referral
- Immunotherapy may slow growth of relapsed mesothelioma
- Mastectomy more common among US women with triple-negative breast cancer
-
- Psychological intervention may ease burden of advanced cancer
- Radiation improves outcomes for right-sided metastatic colorectal tumors
- Shorter duration of trastuzumab for breast cancer halves severe cardiac toxicity, but fails to meet noninferiority
- Three elements of Mediterranean diet most effective for reducing colorectal cancer risk
- Three months of chemotherapy may be sufficient for stage III colon cancer
- Does an indication exist to place IVC filters in patients with cancer who can receive anticoagulation?